Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Meningioma × Aminolevulinic Acid × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 5 Skin Diseases 2 Precancerous Conditions 2 Urinary Bladder Neoplasms 1 Ovarian Neoplasms 1 Meningioma 1 Glioma 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Watchful Waiting 1 Tranexamic Acid 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Protons 1 Proton Therapy 1 Observation 1 Mifepristone 1 Methylphenidate 1 Magnetic Resonance Spectroscopy 1 Fentanyl 1 Donepezil 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305470 2024-06-18

MEN-301

NX Development Corp

Phase 3 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡